Answers are grounded in this paper and cite their sources.
The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70-180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL.
No takes yet. Share an insight, caveat, or question.
Levy et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: